UNOS-based analysis evaluating preservation solution impact in pancreas transplantation, reporting that HTK use was associated with reduced graft survival compared with UW. Frequently cited as evidence that solution choice is not a commodity decision and can materially influence graft outcomes in abdominal transplantation.
Stewart ZA, Cameron AM, Singer AL, Montgomery RA, Segev DL. Histidine-Tryptophan-Ketoglutarate (HTK) Is Associated with Reduced Graft Survival in Pancreas Transplantation. Am J Transplant. 2009;9(1):217–221. doi: 10.1111/j.1600-6143.2008.02449.x. PMID: 18986383. (PubMed)
